SGP SpyGlass Pharma, Inc.
Nasdaq · SEC CIK 1778922 · EDGAR
- Bought, last 12 months
- $221.48M 16 purchases by 15 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 30 since 2026-02-09, latest 2026-02-11
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| RA Capital Healthcare Fund LP | Dir, 10% | $59.04M | — |
| Yang Rick | 10% | $15.00M | — |
| NEA 17 GP, LLC | 10% | $15.00M | — |
| Chang Carmen | 10% | $15.00M | — |
| Makhzoumi Mohamad | 10% | $15.00M | — |
| Behbahani Ali | Dir, 10% | $15.00M | — |
| Florence Anthony A. Jr. | 10% | $15.00M | — |
| Walker Paul Edward | 10% | $15.00M | — |
| Mathers Edward T | 10% | $15.00M | — |
| BASKETT FOREST | 10% | $15.00M | — |
Transactions 30
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2026-02-11 | 2026-02-09 | SGP | Pardo Geoffrey B | Dir | C - Cnv Deriv | $0.00 | +1.88M | 1.88M | New | $0 |
| DI | 2026-02-11 | 2026-02-09 | SGP | Pardo Geoffrey B | Dir | P - Purchase | $16.00 | +312.5K | 2.19M | +17% | +$5.00M |
| DMI | 2026-02-11 | 2026-02-09 | SGP | SANDELL SCOTT D | 10% | C - Cnv Deriv | — | +6.45M | 1.62M | New | — |
| DI | 2026-02-11 | 2026-02-09 | SGP | SANDELL SCOTT D | 10% | P - Purchase | $16.00 | +937.5K | 6.04M | +18% | +$15.00M |
| DMI | 2026-02-11 | 2026-02-09 | SGP | Florence Anthony A. Jr. | 10% | C - Cnv Deriv | — | +6.45M | 2.99M | New | — |
| DI | 2026-02-11 | 2026-02-09 | SGP | Florence Anthony A. Jr. | 10% | P - Purchase | $16.00 | +937.5K | 6.04M | +18% | +$15.00M |
| DI | 2026-02-11 | 2026-02-09 | SGP | Mathers Edward T | 10% | P - Purchase | $16.00 | +937.5K | 6.04M | +18% | +$15.00M |
| DMI | 2026-02-11 | 2026-02-09 | SGP | Mathers Edward T | 10% | C - Cnv Deriv | — | +5.10M | 1.62M | New | — |
| DMI | 2026-02-11 | 2026-02-09 | SGP | Chang Carmen | 10% | C - Cnv Deriv | — | +6.45M | 1.62M | New | — |
| DI | 2026-02-11 | 2026-02-09 | SGP | Chang Carmen | 10% | P - Purchase | $16.00 | +937.5K | 6.04M | +18% | +$15.00M |
| DMI | 2026-02-11 | 2026-02-09 | SGP | Behbahani Ali | Dir, 10% | C - Cnv Deriv | — | +6.45M | 955.0K | New | — |
| DI | 2026-02-11 | 2026-02-09 | SGP | Behbahani Ali | Dir, 10% | P - Purchase | $16.00 | +937.5K | 6.04M | +18% | +$15.00M |
| 2026-02-11 | 2026-02-09 | SGP | Khan Bilal Arshad | Dir | P - Purchase | $16.00 | +20.0K | 25.4K | +367% | +$320.0K | |
| I | 2026-02-11 | 2026-02-09 | SGP | Khan Bilal Arshad | Dir | P - Purchase | $16.00 | +115.0K | 251.4K | +84% | +$1.84M |
| D | 2026-02-11 | 2026-02-09 | SGP | NEA 17 GP, LLC | 10% | P - Purchase | $16.00 | +937.5K | 6.04M | +18% | +$15.00M |
| DM | 2026-02-11 | 2026-02-09 | SGP | NEA 17 GP, LLC | 10% | C - Cnv Deriv | — | +5.10M | 5.10M | New | — |
| DMI | 2026-02-11 | 2026-02-09 | SGP | RA Capital Healthcare Fund LP | Dir, 10% | P - Purchase | $16.00 | +3.69M | 5.97M | +162% | +$59.04M |
| DMI | 2026-02-11 | 2026-02-09 | SGP | RA Capital Healthcare Fund LP | Dir, 10% | C - Cnv Deriv | — | +4.33M | 2.52M | New | — |
| DMI | 2026-02-11 | 2026-02-09 | SGP | BASKETT FOREST | 10% | C - Cnv Deriv | — | +6.45M | 2.99M | New | — |
| DI | 2026-02-11 | 2026-02-09 | SGP | BASKETT FOREST | 10% | P - Purchase | $16.00 | +937.5K | 6.04M | +18% | +$15.00M |
| DMI | 2026-02-11 | 2026-02-09 | SGP | Walker Paul Edward | 10% | C - Cnv Deriv | — | +6.45M | 5.10M | New | — |
| DI | 2026-02-11 | 2026-02-09 | SGP | Walker Paul Edward | 10% | P - Purchase | $16.00 | +937.5K | 6.04M | +18% | +$15.00M |
| DMI | 2026-02-11 | 2026-02-09 | SGP | Yang Rick | 10% | C - Cnv Deriv | — | +5.10M | 5.10M | New | — |
| DI | 2026-02-11 | 2026-02-09 | SGP | Yang Rick | 10% | P - Purchase | $16.00 | +937.5K | 6.04M | +18% | +$15.00M |
| DMI | 2026-02-11 | 2026-02-09 | SGP | Makhzoumi Mohamad | 10% | C - Cnv Deriv | — | +6.45M | 4.36M | New | — |
| DI | 2026-02-11 | 2026-02-09 | SGP | Makhzoumi Mohamad | 10% | P - Purchase | $16.00 | +937.5K | 6.04M | +18% | +$15.00M |
| DMI | 2026-02-10 | 2026-02-09 | SGP | Nielsen Kirk G. | Dir | C - Cnv Deriv | — | +3.15M | 3.15M | New | — |
| DI | 2026-02-10 | 2026-02-09 | SGP | Nielsen Kirk G. | Dir | P - Purchase | $16.00 | +165.0K | 3.31M | +5% | +$2.64M |
| DMI | 2026-02-10 | 2026-02-09 | SGP | Vensana Capital I GP, LLC | 10% | C - Cnv Deriv | — | +3.15M | 2.79M | New | — |
| DI | 2026-02-10 | 2026-02-09 | SGP | Vensana Capital I GP, LLC | 10% | P - Purchase | $16.00 | +165.0K | 3.31M | +5% | +$2.64M |
Purchase Sale Sale after option exercise All abbreviations